My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 152

    1.

    Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins.

    Asakawa H, Koizumi H, Koike A, Takahashi M, Wu W, Iwase H, Fukuda M, Ohta T.

    Breast Cancer Res. 2010;12(2):R17. Epub 2010 Mar 5.

    PMID:
    20205718
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    2.

    HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination.

    Tiezzi DG, Andrade JM, Ribeiro-Silva A, Zola FE, Marana HR, Tiezzi MG.

    BMC Cancer. 2007 Feb 26;7:36.

    PMID:
    17324279
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    3.

    Final Report on Carcinogens Background Document for Styrene.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.

    PMID:
    20737009
    [PubMed - as supplied by publisher]

    Related citations

    4.

    Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.

    Rody A, Karn T, Gätje R, Kourtis K, Minckwitz G, Loibl S, Munnes M, Ruckhäberle E, Holtrich U, Kaufmann M, Ahr A.

    Zentralbl Gynakol. 2006 Apr;128(2):76-81.

    PMID:
    16673249
    [PubMed - indexed for MEDLINE]

    Related citations

    5.

    Low LATS2 mRNA level can predict favorable response to epirubicin plus cyclophosphamide, but not to docetaxel, in breast cancers.

    Takahashi Y, Miyoshi Y, Morimoto K, Taguchi T, Tamaki Y, Noguchi S.

    J Cancer Res Clin Oncol. 2007 Aug;133(8):501-9. Epub 2007 Feb 13.

    PMID:
    17297610
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    Is drug-induced toxicity a good predictor of response to neo-adjuvant chemotherapy in patients with breast cancer?--a prospective clinical study.

    Chintamani, Singhal V, Singh JP, Lyall A, Saxena S, Bansal A.

    BMC Cancer. 2004 Aug 13;4:48.

    PMID:
    15310398
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    7.

    Utility of DNA repair protein foci for the detection of putative BRCA1 pathway defects in breast cancer biopsies.

    Willers H, Taghian AG, Luo CM, Treszezamsky A, Sgroi DC, Powell SN.

    Mol Cancer Res. 2009 Aug;7(8):1304-9. Epub 2009 Aug 11.

    PMID:
    19671671
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    8.

    Final Report on Carcinogens Background Document for Formaldehyde.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.

    PMID:
    20737003
    [PubMed - as supplied by publisher]

    Related citations

    9.

    High pathologic complete response in HER 2-positive locally advanced breast cancer after primary systemic chemotherapy with weekly docetaxel and epirubicin.

    Chen SC, Chang HK, Lin YC, Hsueh S, Cheung YC, Leung WM, Tsai CS, Lo YF, Tsai HP, Shen SC, Chen MF.

    Jpn J Clin Oncol. 2008 Feb;38(2):99-105. Epub 2008 Feb 12.

    PMID:
    18270380
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    10.

    Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study.

    von Minckwitz G, Rezai M, Loibl S, Fasching PA, Huober J, Tesch H, Bauerfeind I, Hilfrich J, Eidtmann H, Gerber B, Hanusch C, Kühn T, du Bois A, Blohmer JU, Thomssen C, Dan Costa S, Jackisch C, Kaufmann M, Mehta K, Untch M.

    J Clin Oncol. 2010 Apr 20;28(12):2015-23. Epub 2010 Mar 22.

    PMID:
    20308671
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage.

    Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM.

    Curr Biol. 2000 Jul 27-Aug 10;10(15):886-95.

    PMID:
    10959836
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer.

    Taucher S, Rudas M, Mader RM, Gnant M, Sporn E, Dubsky P, Roka S, Bachleitner T, Fitzal F, Kandioler D, Wenzel C, Steger GG, Mittlböck M, Jakesz R.

    Breast Cancer Res Treat. 2003 Dec;82(3):207-13.

    PMID:
    14703068
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast.

    von Minckwitz G, Sinn HP, Raab G, Loibl S, Blohmer JU, Eidtmann H, Hilfrich J, Merkle E, Jackisch C, Costa SD, Caputo A, Kaufmann M; German Breast Group.

    Breast Cancer Res. 2008;10(2):R30. Epub 2008 Apr 1.

    PMID:
    18380893
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    14.

    Relationship between hormonal receptors, HER-2, p53 protein, Bcl-2, and MIB-1 status and the antitumor effects of neoadjuvant anthracycline-based chemotherapy in invasive breast cancer patients.

    Kariya S, Ogawa Y, Nishioka A, Moriki T, Ohnishi T, Ito S, Murata Y, Yoshida S.

    Radiat Med. 2005 May;23(3):189-94.

    PMID:
    15940066
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Predictive value of syndecan-1 expression for the response to neoadjuvant chemotherapy of primary breast cancer.

    Götte M, Kersting C, Ruggiero M, Tio J, Tulusan AH, Kiesel L, Wülfing P.

    Anticancer Res. 2006 Jan-Feb;26(1B):621-7.

    PMID:
    16739330
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    Proliferating fraction during neoadjuvant chemotherapy of primary breast cancer in relation to objective local response and relapse-free survival.

    Billgren AM, Rutqvist LE, Tani E, Wilking N, Fornander T, Skoog L.

    Acta Oncol. 1999;38(5):597-601.

    PMID:
    10427948
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy.

    Darb-Esfahani S, Loibl S, Müller BM, Roller M, Denkert C, Komor M, Schlüns K, Blohmer JU, Budczies J, Gerber B, Noske A, du Bois A, Weichert W, Jackisch C, Dietel M, Richter K, Kaufmann M, von Minckwitz G.

    Breast Cancer Res. 2009;11(5):R69. Epub .

    PMID:
    19758440
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    18.

    Perturbation of DNA repair pathways by proteasome inhibitors corresponds to enhanced chemosensitivity of cells to DNA damage-inducing agents.

    Takeshita T, Wu W, Koike A, Fukuda M, Ohta T.

    Cancer Chemother Pharmacol. 2009 Oct;64(5):1039-46. Epub 2009 Mar 10.

    PMID:
    19274461
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    19.

    [Effects of neoadjuvant chemotherapy of docetaxel combined with and epirubicin or pirarubicin on breast cancer: clinical analysis of 160 cases].

    Li XR, Wang JD, Zhang YJ, Kong QL, Ma B, Li J, Zheng YQ, Chen YQ, Jin YC, Li R.

    Zhonghua Yi Xue Za Zhi. 2009 Jan 13;89(2):87-90. Chinese.

    PMID:
    19489268
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    DNA damage in peripheral blood lymphocytes in patients during combined chemotherapy for breast cancer.

    Sánchez-Suárez P, Ostrosky-Wegman P, Gallegos-Hernández F, Peñarroja-Flores R, Toledo-García J, Bravo JL, Del Castillo ER, Benítez-Bribiesca L.

    Mutat Res. 2008 Apr 2;640(1-2):8-15. Epub 2007 Dec 8.

    PMID:
    18207203
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filter your results:

      Find related data

      Recent activity

      You are here: NCBI > Literature > PubMed
      Write to the Help Desk